Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London [Yahoo! Finance]
Aclarion, Inc. (ACON)
Company Research
Source: Yahoo! Finance
Contract Extension Aligns Aclarion and The London Clinic With Engaging Payers to Increase Access to Nociscan for Both Patients and Referring Physicians BROOMFIELD, CO, June 25, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today they are extending their commercial agreement with the prestigious London Clinic in London, UK. The contract extension establishes a higher price point for Nociscan, engages The London Clinic to secure payer coverage decisions from leading private health insurers, and aligns Aclarion with The London Clinic in expanding access to referring physicians throughout the greater London market. “Aclarion uses MR spectroscopy to analyze the physiological status of lumbar intervertebral discs. Being able to quantify the chemical bio
Show less
Read more
Impact Snapshot
Event Time:
ACON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACON alerts
High impacting Aclarion, Inc. news events
Weekly update
A roundup of the hottest topics
ACON
News
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK [Yahoo! Finance]Yahoo! Finance
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKGlobeNewswire
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonGlobeNewswire
- Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution [Yahoo! Finance]Yahoo! Finance
- Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution [Yahoo! Finance]Yahoo! Finance
ACON
Sec Filings
- 6/26/24 - Form 8-K
- 6/25/24 - Form QUALIF
- 6/20/24 - Form 1-A/A
- ACON's page on the SEC website